Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2018

Dec 17, 2018

33003_dirs_2018-12-17_ad660cfb-a97a-4ff0-a5cd-f428f04a60fd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2018-12-13

Reporting Person: Nagendran Sukumar (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-12-13 Director Stock Option (Right to Buy) $23.58 A 17240 Acquired 2028-12-13 Common Stock (17240) Direct

Footnotes

F1: This option was granted on December 13, 2018 and vests as to one-third of the total number of shares on each of September 12, 2019, September 12, 2020, and September 12, 2021, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.